News
Market Data
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Hikma helps put better health within reach every day for millions of people in more than 50 countries around the world. For more than 40 years, we've been creating high-quality medicines and making them accessible to the people who need them. Headquartered in the UK, we are a global company with a l... Hikma helps put better health within reach every day for millions of people in more than 50 countries around the world. For more than 40 years, we've been creating high-quality medicines and making them accessible to the people who need them. Headquartered in the UK, we are a global company with a local presence across the United States (US), the Middle East and North Africa (MENA) and Europe, and we use our unique insight and expertise to transform cutting-edge science into innovative solutions that transform people's lives. We're committed to our customers, and the people they care for, and by thinking creatively and acting practically, we provide them with a broad range of branded and non-branded generic medicines. Together, our 8,400 colleagues are helping to shape a healthier world that enriches all our communities. We are a leading licensing partner, and through our venture capital arm, are helping bring innovative health technologies to people around the world. Show more
Ask ADVFN Intelligence (AI)
By Anthony O. Goriainoff Hikma Pharmaceuticals PLC said Wednesday that it has resumed the launch of its generic version of GlaxoSmithKline PLC's asthma treatment, Advair Diskus, in the U.S...
By Adria Calatayud Hikma Pharmaceuticals PLC said Thursday that talks have ceased over a potential acquisition of GlaxoSmithKline PLC's pharmaceutical and consumer businesses in Egypt and...
By Ian Walker Hikma Pharmaceuticals PLC said Tuesday that it has entered into a preliminary agreement with GlaxoSmithKline PLC's Egyptian subsidiary to buy certain businesses, and expects to...
By Mauro Orru This week, more European companies issued new guidance for 2020, while others revised expectations in the wake of the coronavirus pandemic compared with last week. However, several...
By Carlo Martuscelli Hikma Pharmaceuticals PLC (HIK.LN) will joint the FTSE 100 index, replacing Shire PLC (SHP.LN), FTSE Russell said Wednesday. FTSE Russell attributed the swap to Shire's...
By Carlo Martuscelli Hikma Pharmaceuticals PLC (HIK.LN) announced Thursday a tie-up with inhaler producer Vectura Group PLC (VEC.LN) to collaborate on the development of generic versions of...
By Micah Maidenberg A federal court agreed that patents Acorda Therapeutics Inc. (ACOR) holds for a multiple sclerosis drug are invalid, sending the pharmaceutical company's shares sharply...
By Michael Dabaie Biotechnology company Acorda Therapeutics Inc. (ACOR) on Friday said it signed a conditioned settlement agreement with Mylan N.V. (MYL) and affiliates over Acorda's...
Acorda Therapeutics Inc. (ACOR) were down 14.8%, to $24.45, Wednesday afternoon as a federal appeals court denied the company's motion for an injunction in its patent litigation with generic...
By Ian Walker Aldermore Group PLC (ALD.LN) said Wednesday that it will appoint Pat Butler as chairman once its 1.1 billion-pound ($1.47 billion) takeover by FirstRand Ltd. (FSR.JO) completes. The...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 3.185 | 6.89170182841 | 46.215 | 49.4 | 46.215 | 380 | 46.78147234 | DR |
| 4 | -0.6 | -1.2 | 50 | 50 | 46.215 | 360 | 47.20621605 | DR |
| 12 | -3.775 | -7.09920075223 | 53.175 | 53.175 | 46.215 | 341 | 49.55821061 | DR |
| 26 | -0.99 | -1.96467553086 | 50.39 | 55.56 | 46.215 | 495 | 49.97410925 | DR |
| 52 | 4.8 | 10.7623318386 | 44.6 | 55.56 | 42.51 | 715 | 48.74867874 | DR |
| 156 | -11.73 | -19.1886144283 | 61.13 | 62.7699 | 25.12 | 1817 | 46.42044853 | DR |
| 260 | -3.21 | -6.10150161566 | 52.61 | 75.81 | 25.12 | 1707 | 48.92953304 | DR |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
